Detalhe da pesquisa
1.
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.
BMC Infect Dis
; 17(1): 420, 2017 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28610605
2.
Efficacy and safety of ombitasvir/paritaprevir/r and dasabuvir compared to IFN-containing regimens in genotype 1 HCV patients: The MALACHITE-I/II trials.
J Hepatol
; 64(1): 19-28, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26321288
3.
Citalopram for the prevention of depression and its consequences in HIV-hepatitis C coinfected individuals initiating pegylated interferon/ribavirin therapy: a multicenter randomized double-blind placebo-controlled trial.
HIV Clin Trials
; 15(4): 161-75, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25143025
4.
Directly observed pegylated interferon plus self-administered ribavirin for the treatment of hepatitis C virus infection in people actively using drugs: a randomized controlled trial.
Clin Infect Dis
; 57 Suppl 2: S90-6, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23884072
5.
Reinfection with hepatitis C virus following sustained virological response in injection drug users.
J Gastroenterol Hepatol
; 25(7): 1281-4, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20594256
6.
Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study.
Int J Drug Policy
; 47: 230-238, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28633998
7.
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study.
Int J Drug Policy
; 47: 177-186, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624134
8.
Optimizing assessment and treatment for hepatitis C virus infection in illicit drug users: a novel model incorporating multidisciplinary care and peer support.
Eur J Gastroenterol Hepatol
; 22(3): 270-7, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20425880
9.
Treatment uptake and outcomes among current and former injection drug users receiving directly observed therapy within a multidisciplinary group model for the treatment of hepatitis C virus infection.
Int J Drug Policy
; 18(5): 437-43, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17854734
10.
Directly observed therapy for the treatment of hepatitis C virus infection in current and former injection drug users.
J Gastroenterol Hepatol
; 22(9): 1519-25, 2007 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-17645460